Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001104659-22-073980

10% owner sold 101,903 shares at an average $12.80 ($1,304,816)

From the SEC's structured data for this filing

Trades in this filing

F2 Bioscience I 2017 Ltd · 10% owner

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-06-21 Sale : show line 1 in the form −22,319 $12.77 $284,929 616,976 D
2022-06-22 Sale : show line 2 in the form −49,953 $12.70 $634,578 567,023 D
2022-06-23 Sale : show line 3 in the form −29,631 $13.00 $385,310 537,392 D
Open-market sales · 101,903 sh · avg $12.80 · $1,304,816
Loading xslF345X03/tm2219298-1_4seq1.xml…